Maeda Y, Hirai T, Yamato H, Kobori N, Matsunaga K, Oguchi Y, Yoshimura M, Fujii T, Kobayashi Y, Saitoh K
Biomedical Research Laboratories, Kureha Chemical Industry Co., Ltd., Tokyo, Japan.
Oncology. 1988;45(3):206-9. doi: 10.1159/000226563.
24R,25(OH)2D3, one of the endogenous active metabolites of vitamin D3, showed suppressive effects on the proliferation of various tumor cells in vitro, and showed a suppressive effect on the growth of human osteosarcoma transplanted in nude mice. 24R,25(OH)2D3 increased bone strength lowered by the tumor burden which causes abnormal calcium metabolism and results in hypercalcemia.